Carolyn McFarlane

Carolyn McFarlane is a seasoned professional in clinical quality assurance with extensive experience in the biopharmaceutical industry. Currently serving as the Director of Clinical Quality at Intercept Pharmaceuticals, Carolyn provides expertise in compliance for clinical SOPs and collaborates on quality strategies across study teams. Previous roles include Director/Head of Clinical Quality at Celyad Oncology, where a new clinical quality assurance program was implemented, and Associate Director at Bristol-Myers Squibb, responsible for creating a streamlined eQMS for audits and inspections. Prior to these positions, Carolyn held leadership roles at Takeda and Memorial Sloan Kettering Cancer Center, demonstrating a consistent commitment to enhancing clinical operations and regulatory compliance. Carolyn holds a Bachelor of Arts in Psychology from Brooklyn College.